181 related articles for article (PubMed ID: 15971117)
1. The benzophenanthridine alkaloid fagaronine induces erythroleukemic cell differentiation by gene activation.
Dupont C; Couillerot E; Gillet R; Caron C; Zeches-Hanrot M; Riou JF; Trentesaux C
Planta Med; 2005 Jun; 71(6):489-94. PubMed ID: 15971117
[TBL] [Abstract][Full Text] [Related]
2. Effects of chebulinic acid on differentiation of human leukemia K562 cells.
Yi ZC; Wang Z; Li HX; Liu MJ; Wu RC; Wang XH
Acta Pharmacol Sin; 2004 Feb; 25(2):231-8. PubMed ID: 14769215
[TBL] [Abstract][Full Text] [Related]
3. In vivo erythroid recovery following paclitaxel injury: correlation between GATA-1, c-MYB, NF-E2, Epo receptor expressions, and apoptosis.
Romero-Benitez MM; Aguirre MV; Juaristi JA; Alvarez MA; Trifaró JM; Brandan NC
Toxicol Appl Pharmacol; 2004 Feb; 194(3):230-8. PubMed ID: 14761679
[TBL] [Abstract][Full Text] [Related]
4. A novel erythroid differentiation related gene EDRF1 upregulating globin gene expression in HEL cells.
Wang D; Li Y; Shen B
Chin Med J (Engl); 2002 Nov; 115(11):1701-5. PubMed ID: 12609092
[TBL] [Abstract][Full Text] [Related]
5. Differential expression and functional role of GATA-2, NF-E2, and GATA-1 in normal adult hematopoiesis.
Labbaye C; Valtieri M; Barberi T; Meccia E; Masella B; Pelosi E; Condorelli GL; Testa U; Peschle C
J Clin Invest; 1995 May; 95(5):2346-58. PubMed ID: 7738198
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional and posttranscriptional regulation of erythroid gene expression in anthracycline-induced differentiation of human erythroleukemic cells.
Morceau F; Chénais B; Gillet R; Jardillier JC; Jeannesson P; Trentesaux C
Cell Growth Differ; 1996 Aug; 7(8):1023-9. PubMed ID: 8853898
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
8. Dependence for the proliferative response to erythropoietin on an established erythroid differentiation program in a human hematopoietic cell line, UT-7.
Nicolis S; Ottolenghi S; Papayannopoulou T; Baiocchi M; Migliaccio G; Adamson J; Migliaccio AR
Exp Hematol; 1993 May; 21(5):665-70. PubMed ID: 8513868
[TBL] [Abstract][Full Text] [Related]
9. Heme-dependent up-regulation of the alpha-globin gene expression by transcriptional repressor Bach1 in erythroid cells.
Tahara T; Sun J; Igarashi K; Taketani S
Biochem Biophys Res Commun; 2004 Nov; 324(1):77-85. PubMed ID: 15464985
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1beta up-regulates the expression of thrombopoietin and transcription factors c-Jun, c-Fos, GATA-1, and NF-E2 in megakaryocytic cells.
Chuen CK; Li K; Yang M; Fok TF; Li CK; Chui CM; Yuen PM
J Lab Clin Med; 2004 Feb; 143(2):75-88. PubMed ID: 14966463
[TBL] [Abstract][Full Text] [Related]
11. Induction of erythroid gene expression by microcell fusion.
Kanamori H; Siegel JN
Exp Cell Res; 1997 Apr; 232(1):90-6. PubMed ID: 9141625
[TBL] [Abstract][Full Text] [Related]
12. Erythroid regulatory elements.
Raich N; Romeo PH
Stem Cells; 1993 Mar; 11(2):95-104. PubMed ID: 8096156
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor alpha inhibits aclacinomycin A-induced erythroid differentiation of K562 cells via GATA-1.
Morceau F; Schnekenburger M; Blasius R; Buck I; Dicato M; Diederich M
Cancer Lett; 2006 Aug; 240(2):203-12. PubMed ID: 16274927
[TBL] [Abstract][Full Text] [Related]
14. A major role for the TATA box in recruitment of chromatin modifying complexes to a globin gene promoter.
Gui CY; Dean A
Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7009-14. PubMed ID: 12773626
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation.
Buck I; Morceau F; Cristofanon S; Heintz C; Chateauvieux S; Reuter S; Dicato M; Diederich M
Biochem Pharmacol; 2008 Nov; 76(10):1229-39. PubMed ID: 18805401
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of the distal, but not of the proximal, Gata1 transcripts during differentiation of primary erythroid cells.
Vannucchi AM; Linari S; Lin CS; Koury MJ; Bondurant MC; Migliaccio AR
J Cell Physiol; 1999 Sep; 180(3):390-401. PubMed ID: 10430179
[TBL] [Abstract][Full Text] [Related]
17. Targeted remodeling of human beta-globin promoter chromatin structure produces increased expression and decreased silencing.
Iler N; Goodwin AJ; McInerney J; Nemeth MJ; Pomerantz O; Layon ME; Lowrey CH
Blood Cells Mol Dis; 1999 Feb; 25(1):47-60. PubMed ID: 10349513
[TBL] [Abstract][Full Text] [Related]
18. Reduction of DNA binding activity of the GATA-1 transcription factor in the apoptotic process induced by overexpression of PU.1 in murine erythroleukemia cells.
Yamada T; Kihara-Negishi F; Yamamoto H; Yamamoto M; Hashimoto Y; Oikawa T
Exp Cell Res; 1998 Nov; 245(1):186-94. PubMed ID: 9828115
[TBL] [Abstract][Full Text] [Related]
19. GATA-1 binding to the alphaV promoter negatively regulates expression of the integrin alphaV subunit in human leukemic K562 cells.
Czyz M; Stasiak M; Boncela J; Cierniewsk CS
Acta Biochim Pol; 2002; 49(1):19-28. PubMed ID: 12136940
[TBL] [Abstract][Full Text] [Related]
20. Increased glutathione S-transferase P1-1 expression by mRNA stabilization in hemin-induced differentiation of K562 cells.
Schnekenburger M; Morceau F; Duvoix A; Delhalle S; Trentesaux C; Dicato M; Diederich M
Biochem Pharmacol; 2004 Sep; 68(6):1269-77. PubMed ID: 15313425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
